ACUTE LUNG INFLAMMATION INDUCED IN THE RABBIT BY LOCAL INSTILLATION OF 1-0-OCTADECYL-2-ACETYL-SN-GLYCERYL-3-PHOSPHORYLCHOLINE OR OF NATIVE PLATELET-ACTIVATING FACTOR
- 1 January 1983
- journal article
- research article
- Vol. 112 (1) , 78-88
Abstract
The intratracheal instillation into rabbits of 1-0-octadecyl-2-acetyl-sn-glyceryl-3-phosphorylcholine (AGEPC) or native platelet-activating factor (PAF) induced a dose-dependent acute pulmonary inflammation characterized by accumulation of macrophages in the alveolar space, degenerative and necrotic changes of alveolar epithelium, and accumulation of polymorphonuclear leukocytes (PMN) and platelets in the alveolar capillary lumens with degenerative changes of endothelial cells. Infiltration of alveolar septa by inflammatory cells and, in a later stage, pulmonary fibrosis were also observed. Intrabronchial instillation of lysoglyceryl ether phosphorylcholine (lyso-GEPC) produced no inflammatory changes or only mild ones. In comparison with acute inflammation induced by intratracheal instillation of C5a [complement component 5a] des Arg, which is mainly characterized by the presence of neutrophils, red blood cells, and fibrin in the alveolar space, AGEPC and native PAF seem to induce a more severe accumulation of macrophages in the alveolar space and septa and of platelet and PMN in the lumens of alveolar capillaries. The results are compatible with the concept that during inflammatory reaction an intraalveolar release of PAF contributes to the development of pulmonary injury.This publication has 38 references indexed in Scilit:
- Release of platelet‐activating factor (PAF‐acether) from alveolar macrophages by the calcium ionophore A 23187 and phagocytosisEuropean Journal of Clinical Investigation, 1980
- Platelet-Activating Factor (PAF-Acether) Secretion from Platelets: Effect of Aggregating AgentsBritish Journal of Haematology, 1980
- Novel effects of 1-0-hexadecyl-2-acyl-sn-glycero-3-phosphorylcholine mediators on human leukocyte function: Delineation of the specific roles of the acyl substituentsBiochemical and Biophysical Research Communications, 1980
- Chemotactic activity of C5ades Arg: Evidence of a requirement for an anionic peptide ‘helper factor’ and inhibition by a cationic protein in serum from patients with systemic lupus erythematosusMolecular Immunology, 1980
- Platelet‐activating factor and macrophages. I. Evidence for the release from rat and mouse peritoneal macrophages and not from mastocytesEuropean Journal of Immunology, 1979
- Induction of Acute Inflammatory Reactions in Lung following Intrapulmonary Instillation of Preformed Chemotactic Peptides and Purified Complement ComponentsChest, 1979
- Activation and desensitization of platelets by platelet-activating factor (PAF) derived from IgE-sensitized basophils. I. Characteristics of the secretory response.The Journal of Experimental Medicine, 1976
- EXPERIMENTAL IMMUNE COMPLEX DISEASE OF THE LUNGThe Journal of Experimental Medicine, 1974
- FORMATION OF C3a AND C5a ANAPHYLATOXINS IN WHOLE HUMAN SERUM AFTER INHIBITION OF THE ANAPHYLATOXIN INACTIVATORThe Journal of Experimental Medicine, 1973
- LEUKOCYTE-DEPENDENT HISTAMINE RELEASE FROM RABBIT PLATELETSThe Journal of Experimental Medicine, 1972